Cmi-206: A potent dual platelet activating factor antagonist and 5-lipoxygenase inhibitor

Cmi-206: A potent dual platelet activating factor antagonist and 5-lipoxygenase inhibitor (±)-trans-2-[3-Methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a Potent Dual 5-Lipoxygenase Inhibitor and Platelet-Activating Factor Receptor Antagonist Platelet activating factor (PAF) antagonists: synthesis and structure-activity studies of novel PAF analogs modified in the phosphorylcholine moiety FR-900452, a specific antagonist of platelet activating factor (PAF) produced by Streptomyces phaeofaciens. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics. Synthesis and 5-Lipoxygenase Inhibitory Activities of Some Novel 2-Substituted 5-Benzofuran Hydroxamic Acids Analogs of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring 5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds Synthesis and Activity of a New Methoxytetrahydropyran Derivative as Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitor Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents Magnone A and B, Novel Anti-PAF Tetrahydrofuran Lignans from the Flower Buds of<i>Magnolia fargesii</i>